Hird, Megan A.
Sandoe, Claire H.
Article History
Accepted: 18 May 2023
First Online: 5 June 2023
Declarations
:
: MAH: no conflicts to declare. CHS: Abbvie, Eli Lilly, Lundbeck, Miravo, Novartis, Teva (Advisory Board); Eli Lilly, Novartis (Consulting), Novartis (Speaking).
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).